Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Inclusion of biopiperine in the kappa-carrageenan complex might improve its bioaccessibility and in vivo anti-inflammatory activity in edema-induced Wistar rats

Nela Simanjuntak, Jutti Levita, Anas Subarnas.




Abstract
Cited by 5 Articles

Piper nigrum has been used in Indonesian traditional medicine to alleviate pain. Piperine, a nitrogenous substance isolated from the plant has been reported for its anti-inflammatory activity. However, this compound is slightly soluble in water, which impacts its bioaccessibility. A recent study reported that a co-ground mixture of piperine and β-cyclodextrin revealed a significant increase of dissolved piperine at 15 min of dissolution test compared to that of pure piperine. This work was aimed to study the bioaccessibility of the carrageenan complexed-piperine in Wistar rats and assayed its anti-inflammatory activity on the edema-induced paw of the rats. Both isolated (from Piper nigrum) and synthetic (TCI, Tokyo Chemical Industry) piperines were used as the standards for the bioaccessibility assay, whereas acetosal was the standard drug for the anti-inflammatory activity study. The carrageenan complexed-piperine revealed better bioaccessibility (Cmax=0.34 µg/ml; Tmax at 30 minutes) than that of the isolated-piperine (Cmax=0.12 µg/ml, Tmax at 60 minutes), while the synthetic piperine showed the best absorption (Cmax=0.48 µg/ml, Tmax at 30 minutes). The anti-inflammatory activity of carrageenan complexed-piperine at a dose of 393 mg/kg BW (contains 100 mg of piperine) equals to acetosal dose of 45 mg/kg BW. Thus, the inclusion of bio-piperine in the carrageenan complex might improve its bioaccessibility and in vivo anti-inflammatory activity in Wistar rats.

Key words: anti-inflammatory, carrageenan, Piperaceae, piperine






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.